Prior to joining the World Economic Forum as Senior Director of Global Health and Healthcare, Arnaud was Senior Vice President at Royal Philips in charge of Global Strategy, Business Development, and Mergers & Acquisitions (M&A) for Philips Healthcare, the $13B in sales unit of Royal Philips based in Boston.
Formally the Senior Vice President and Chief Financial Officer for Philips Home Healthcare Solutions, Arnaud joined Philips in 2005 from Baxter Healthcare, where he acted as the European Regional Controller for Baxter $2.5B business. A finance MBA from HEC Paris by education, Arnaud has accumulated more than 20 years of experience in the Healthcare industry, and more recently completed about 25 M&A transactions with a particular focus on targets in the space of Home Healthcare, Clinical Decision Support, Imaging and Image Guided Intervention and Treatment.
Victor J. Dzau is President of the National Academy of Medicine, Chancellor Emeritus at Duke University and former CEO of the Duke University Health System. Professor Dzau has made a significant impact through his seminal research in cardiovascular medicine and his leadership in health care innovation. He has led the creation of the Division of Global Health Equity at Brigham & Women’s Hospital (with Paul Farmer & Jim Kim), Duke Translational Medicine Institute, Duke Global Health Institute, Duke-National University of Singapore Graduate Medical School, and Duke Institute for Health Innovation. He has served on the Advisory Committee to the Director of National Institutes of Health (NIH) and chaired the NIH Cardiovascular Disease Advisory Committee. Currently he is a member of the Board of the Singapore Health System, Hamad Medical Corporation, Qatar, the Expert Board of the Imperial College Health Partners, UK, and the International Advisory Board of the Biomedical Science Council of Singapore. He chaired the Global Agenda Council on Personalized and Precision Medicine of the World Economic Forum. Among his many honors are the Gustav Nylin Medal from the Swedish Royal College of Medicine, Distinguished Scientist Award from American Heart Association and the Public Service Medal from the President of Singapore.
Dr. Nicolaus Henke is a Senior Partner at McKinsey & Company. He advises leading companies on how to improve decision making and performance through advanced analytics, artificial intelligence and end-to-end data enabled transformations. Nicolaus is global leader of McKinsey Analytics, which has more than 2000 dedicated analytics practitioners and translators. Within this role he oversees partnerships between McKinsey and the wider artificial intelligence, data and computing ecosystem.
Nicolaus is the Chairman of QuantumBlack, a company operating at the intersection of strategy, technology and design, which was acquired by McKinsey in 2015. Nicolaus is also a member of McKinsey's global Board, the Shareholders Council. He is a member of the Board of Innovations in Healthcare at Duke Health, which he helped found, and serves on the Dean's Advisory Council, Harvard Kennedy School.
Nicolaus frequently speaks on big data, analytics and healthcare topics at global fora such as the World Economic Forum, the Milken Institute, and Forbes.
Nicolaus graduated with distinction with a Master’s and Doctorate degree in Business from the University of Münster, Germany. He also holds a Master’s in Public Administration from Harvard University, where he was a John J McCloy Scholar.
Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Policy, and Director of the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care including payment reform, real-world evidence and more effective drug and device innovation. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. He was previously Senior Fellow at the Brookings Institution and a faculty member at Stanford University.
Michael H. Merson, M.D. is the founding director of the Duke Global Health Institute and the Wolfgang Joklik Professor of Global Health at Duke University. In addition, Dr. Merson is the University’s Vice President and Vice Provost for Global Affairs and from 2010-2016 served as its Vice Chancellor for Duke-National University of Singapore Affairs. Merson is a graduate of Amherst College and the State University of New York, Downstate Medical Center. He has held leadership positions at the Centers for Disease Control, Cholera Research Laboratory in Bangladesh, and the World Health Organization, including the WHO Global Program on AIDS from 1990-1995. In 1995, Merson was appointed the first Dean of Public Health at Yale University and in 2001 became director of the Yale Center for Interdisciplinary Research on AIDS. He is senior editor of Global Health: Disease, Programs, Systems, and Policies, a leading global health textbook. He has advised UNAIDS, WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, World Bank, Doris Duke Foundation, and the Bill and Melinda Gates Foundation.
An acclaimed scientist and malariologist, Christopher Plowe, MD, MPH, F.A.S.T.M.H., is recognized internationally for his groundbreaking work on the molecular epidemiology of drug-resistant and "vaccine-resistant" malaria.
Prior to coming to DGHI in 2018, Dr. Plowe was the Frank M. Calia, MD Professor of Medicine and founding director of the Institute for Global Health at the University of Maryland. His malaria research group at the University of Maryland oversaw research in Africa, where he helped establish field research sites in Mali and Malawi, and in Asia, where he is a frequent traveler to new field sites in Myanmar.
While much of today's research on malaria focuses on developing new drugs or vaccines that might save lives in the future, Dr. Plowe's strategy aims to save lives right now by developing new tools to help countries eliminate malaria. His team is using molecular and genomics approaches to track the emergence and spread of drug resistance and to map the "silent reservoir" of malaria parasites responsible for transmission of new infections. He is also working to develop a vaccine that will be effective against genetically diverse malaria parasites that have shown the ability to escape the effects of first generation malaria vaccines.
Dr. Plowe received his MD degree from Cornell University Medical College and his MPH at the Columbia University School of Public Health. He completed his residency at St. Luke's Hospital in and his clinical infectious diseases fellowship at the Johns Hopkins School of Medicine.
Dr. Krishna Udayakumar leads multiple initiatives at Duke in the rapidly evolving fields of health innovation and globalization of healthcare. He is Executive Director of Innovations in Healthcare, a non-profit co-founded by Duke, McKinsey & Company, and the World Economic Forum, leading all aspects of the organization’s work to support the scale and replication of transformative health solutions globally. He also leads the newly established Global Health Innovation Center at Duke University, focused on generating deeper evidence and support for the study and scaling of health innovations globally.
As Head of Global Innovation for Duke Health, Dr. Udayakumar is responsible for the development and implementation of global strategy as well as global business development for Duke Health, across healthcare delivery, biomedical sciences research, and health professions education and training.
At Duke University, Dr. Udayakumar holds the rank of Associate Professor of Global Health and Medicine, and is an Associate Professor at Duke-NUS Medical School Singapore. His work has been published in leading academic journals such as the New England Journal of Medicine, Health Affairs, and Academic Medicine.
Born in Bangalore, India, Dr. Udayakumar spent his childhood in Virginia, and is a Phi Beta Kappa graduate of the University of Virginia, with a bachelor’s degree in interdisciplinary studies with distinction. He received both an MD and an MBA (with a concentration in Health Sector Management) from Duke University, where he was a Fuqua Scholar. Dr. Udayakumar completed his residency training in internal medicine at Duke and served as Assistant Chief Resident at the Durham VA Medical Center before joining the faculty of Duke University.